Switch in use of midazolam for cancer patients during the COVID-19 pandemic
J Oncol Pharm Pract
.
2020 Oct;26(7):1817-1818.
doi: 10.1177/1078155220948929.
Epub 2020 Aug 14.
Authors
Guillaume Marliot
1
,
Nicolas Penel
2
3
,
Vincent Gamblin
3
4
Affiliations
1
Pharmacy Department, Centre Oscar Lambret, Lille, France.
2
Medical Oncology Department, Centre Oscar Lambret, Lille, France.
3
Medical School, Lille University, Lille, France.
4
Palliative Care Unit, Centre Oscar Lambret, Lille, France.
PMID:
32791947
DOI:
10.1177/1078155220948929
No abstract available
Publication types
Letter